Nickolay Kukekov V. - 13 Feb 2024 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
Director
Signature
/s/ Nickolay Kukekov
Issuer symbol
BRTX
Transactions as of
13 Feb 2024
Net transactions value
$0
Form type
4
Filing time
15 Feb 2024, 16:23:05 UTC
Previous filing
17 Feb 2023
Next filing
19 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRTX Stock Option Award $0 +79,646 $0.000000 79,646 13 Feb 2024 Common Stock 79,646 $1.45 Direct F3
holding BRTX Stock Option 25,236 13 Feb 2024 Common Stock 25,236 $5.08 Direct F1
holding BRTX Stock Option 32,028 13 Feb 2024 Common Stock 32,028 $2.91 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Nickolay Kukekov V. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable to the extent of 12,618 shares on November 4, 2021 with the remaining 12,618 shares vesting quarterly in eight nearly equal installments beginning November 4, 2022 and continuing every three months thereafter until fully vested.
F2 The option vests and becomes exercisable in twelve monthly installments of 2,669 shares beginning on March 17, 2023 and continuing each month thereafter until fully vested.
F3 The option vests and becomes exercisable in twelve nearly equal monthly installments of 6,637 shares beginning on March 13, 2024 and continuing each month thereafter until fully vested.